Is ultrasonic nebulization (nebulization using ultrasonic (high frequency sound) waves) avoided for colistin (polymyxin E) administration due to heat degradation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ultrasonic Nebulization and Colistin: Heat Degradation Concerns

The concern about ultrasonic nebulizers heating and degrading colistin is not supported by the evidence—both ultrasonic and jet nebulizers preserve colistin's antimicrobial activity, and current guidelines actually recommend ultrasonic or vibrating plate nebulizers over standard jet nebulizers for optimal drug delivery. 1, 2

Evidence Against Heat Degradation

  • A direct bench study comparing jet (Pari LL) and ultrasonic (DP100) nebulizers found that neither jet nebulization nor ultrasonic nebulization altered the antibiotic properties of colistin, with post-nebulization minimum inhibitory concentrations (MICs) remaining within acceptable ranges (1.9 μg/mL for ultrasonic vs 0.5 μg/mL for jet, compared to 1 μg/mL for non-nebulized colistin—all within two dilutions of each other) 3

  • The study specifically tested anti-Pseudomonas aeruginosa activity after nebulization and concluded that both systems can be used to nebulize colistin without compromising drug efficacy 3

Current Guideline Recommendations

  • The Intensive Care Medicine task force explicitly recommends that nebulized antibiotics should be delivered using ultrasonic or vibrating plate nebulizers (AII level evidence), not standard jet nebulizers 1, 2

  • The American College of Chest Physicians supports this recommendation, noting that ultrasonic or vibrating plate nebulizers provide superior drug delivery compared to conventional jet nebulizers 2

  • The European Respiratory Journal consensus acknowledges that nebulization times may be much shorter using ultrasonic devices than using jet nebulizers, which is actually an advantage for patient compliance 1

Why the Misconception Exists

  • While it's true that ultrasonic nebulizers can generate heat through the vibration mechanism, and that ultrasonic and jet nebulizers may damage protein and other complex agents through heat or shear stress 4, this concern has been specifically tested for colistin and found to be clinically insignificant 3

  • The theoretical concern about heat degradation does not translate into actual loss of antimicrobial activity for colistin, as demonstrated by direct microbiological testing 3

Practical Implications

  • Standard jet nebulizers are actually inadequate for proper drug delivery according to the Society of Critical Care Medicine, making ultrasonic or vibrating plate devices the preferred choice 2

  • Using standard jet nebulizers instead of ultrasonic or vibrating plate nebulizers can lead to inadequate drug delivery, which is a common pitfall warned against by the American College of Chest Physicians 2

  • The particle size (2-5 μm range) and drug output are more important considerations than the theoretical heat generation, and modern ultrasonic/vibrating plate devices optimize these parameters 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nebulized Colistin in the ICU: Indications, Technique, and Dosing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nebulization and anti-Pseudomonas aeruginosa activity of colistin.

The European respiratory journal, 1997

Research

Formulations and nebulizer performance.

Respiratory care, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.